Published online before print December 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
,
Departments of *Ophthalmology, ¶Immunology, and #Molecular Genetics and Biochemistry and
Graduate Program in Immunology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA;
Department of Surgery, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA;
Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan; and ||Earl A. Chiles Research Institute, Providence Medical Center, Portland, Oregon, USA
@ To whom correspondence should be addressed. E-mail: hendricksrr{at}msx.upmc.edu.
Herpes stromal keratitis (HSK) is an immunopathological disease regulated by Th1 CD4 T cells, which require APC and costimulation within the infected cornea to mediate disease. Recent studies suggest the OX40:OX40 ligand (OX40L) interaction enhances effector cell cytokine secretion at inflammatory sites. OX40+ cells were detected in HSV-1-infected mouse corneas as early as 3 days postinfection (dpi), prior to the onset of HSK, and their frequency increased through 15 dpi, when all mice exhibited severe HSK. OX40L+ cells were first detected at 7 dpi, coincident with the initiation of HSK. It is interesting that the OX40L+ cells did not coexpress MHC Class II or the dendritic cell (DC) marker CD11c. Our findings demonstrate rapid infiltration of activated (OX40+) CD4+ T cells into HSV-1-infected corneas and expression of OX40L on MHC Class II-negative cells but surprisingly, not on MHC Class II+ CD11C+ DC, which are present in the infected corneas and required for HSK. Moreover, neither local nor systemic treatment of mice with a blocking antibody to OX40L or with a blocking fusion protein altered the course of HSK significantly, possibly as a result of a lack of OX40L expression on functional APC.
Key Words: HSV-1 CD4 mouse cornea immunopathology
This article has been cited by other articles:
![]() |
M. Walch, S. K. Rampini, I. Stoeckli, S. Latinovic-Golic, C. Dumrese, H. Sundstrom, A. Vogetseder, J. Marino, D. L. Glauser, M. van den Broek, et al. Involvement of CD252 (CD134L) and IL-2 in the Expression of Cytotoxic Proteins in Bacterial- or Viral-Activated Human T Cells J. Immunol., June 15, 2009; 182(12): 7569 - 7579. [Abstract] [Full Text] [PDF] |
||||